129 related articles for article (PubMed ID: 26999488)
1. Use of Quantitative Dynamic Contrast-Enhanced Ultrasound to Assess Response to Antiangiogenic Therapy in Children and Adolescents With Solid Malignancies: A Pilot Study.
McCarville MB; Coleman JL; Guo J; Li Y; Li X; Honnoll PJ; Davidoff AM; Navid F
AJR Am J Roentgenol; 2016 May; 206(5):933-9. PubMed ID: 26999488
[TBL] [Abstract][Full Text] [Related]
2. Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.
Lassau N; Bonastre J; Kind M; Vilgrain V; Lacroix J; Cuinet M; Taieb S; Aziza R; Sarran A; Labbe-Devilliers C; Gallix B; Lucidarme O; Ptak Y; Rocher L; Caquot LM; Chagnon S; Marion D; Luciani A; Feutray S; Uzan-Augui J; Coiffier B; Benastou B; Koscielny S
Invest Radiol; 2014 Dec; 49(12):794-800. PubMed ID: 24991866
[TBL] [Abstract][Full Text] [Related]
3. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
Merz M; Komljenovic D; Semmler W; Bäuerle T
Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
[TBL] [Abstract][Full Text] [Related]
4. Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.
Lassau N; Koscielny S; Chami L; Chebil M; Benatsou B; Roche A; Ducreux M; Malka D; Boige V
Radiology; 2011 Jan; 258(1):291-300. PubMed ID: 20980447
[TBL] [Abstract][Full Text] [Related]
5. Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study.
Lassau N; Chapotot L; Benatsou B; Vilgrain V; Kind M; Lacroix J; Cuinet M; Taieb S; Aziza R; Sarran A; Labbe C; Gallix B; Lucidarme O; Ptak Y; Rocher L; Caquot LM; Chagnon S; Marion D; Luciani A; Uzan-Augui J; Koscielny S
Invest Radiol; 2012 Dec; 47(12):711-6. PubMed ID: 23095862
[TBL] [Abstract][Full Text] [Related]
6. Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.
Zhou J; Zhang H; Wang H; Lutz AM; El Kaffas A; Tian L; Hristov D; Willmann JK
Angiogenesis; 2017 Nov; 20(4):547-555. PubMed ID: 28721500
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment assessment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy.
Han KS; Jung DC; Choi HJ; Jeong MS; Cho KS; Joung JY; Seo HK; Lee KH; Chung J
Cancer; 2010 May; 116(10):2332-42. PubMed ID: 20225226
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of early response to antiangiogenic treatment with dynamic contrast enhanced ultrasound].
Lassau N; Brule A; Chami L; Benatsou B; Péronneau P; Roche A
J Radiol; 2008 May; 89(5 Pt 1):549-55. PubMed ID: 18535495
[TBL] [Abstract][Full Text] [Related]
9. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
10. Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors.
Interiano RB; McCarville MB; Wu J; Davidoff AM; Sandoval J; Navid F
J Pediatr Surg; 2015 Sep; 50(9):1484-9. PubMed ID: 25783402
[TBL] [Abstract][Full Text] [Related]
11. Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results.
Frampas E; Lassau N; Zappa M; Vullierme MP; Koscielny S; Vilgrain V
Eur J Radiol; 2013 May; 82(5):e205-11. PubMed ID: 23273822
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
[TBL] [Abstract][Full Text] [Related]
13. MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma.
Kickingereder P; Radbruch A; Burth S; Wick A; Heiland S; Schlemmer HP; Wick W; Bendszus M; Bonekamp D
Radiology; 2016 May; 279(2):542-52. PubMed ID: 26579564
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of high frequency ultrasound methods and contrast agents for characterising tumor response to anti-angiogenic treatment.
Rix A; Lederle W; Siepmann M; Fokong S; Behrendt FF; Bzyl J; Grouls C; Kiessling F; Palmowski M
Eur J Radiol; 2012 Oct; 81(10):2710-6. PubMed ID: 22093958
[TBL] [Abstract][Full Text] [Related]
15. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound.
Zocco MA; Garcovich M; Lupascu A; Di Stasio E; Roccarina D; Annicchiarico BE; Riccardi L; Ainora ME; Ponziani F; Caracciolo G; Rapaccini GL; Landolfi R; Siciliano M; Pompili M; Gasbarrini A
J Hepatol; 2013 Nov; 59(5):1014-21. PubMed ID: 23811306
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: a preliminary study.
Wang J; Chen LT; Tsang YM; Liu TW; Shih TT
AJR Am J Roentgenol; 2004 Sep; 183(3):713-9. PubMed ID: 15333360
[TBL] [Abstract][Full Text] [Related]
17. Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy.
Averkiou M; Lampaskis M; Kyriakopoulou K; Skarlos D; Klouvas G; Strouthos C; Leen E
Ultrasound Med Biol; 2010 Jan; 36(1):68-77. PubMed ID: 19900749
[TBL] [Abstract][Full Text] [Related]
18. Color-coded perfusion analysis of CEUS for pre-interventional diagnosis of microvascularisation in cases of vascular malformations.
Teusch VI; Wohlgemuth WA; Piehler AP; Jung EM
Clin Hemorheol Microcirc; 2014; 58(1):183-93. PubMed ID: 25227194
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US.
McCarville MB; Streck CJ; Dickson PV; Li CS; Nathwani AC; Davidoff AM
Radiology; 2006 Jul; 240(1):73-81. PubMed ID: 16793972
[TBL] [Abstract][Full Text] [Related]
20. Regions of interest and parameters for the quantitative analysis of contrast-enhanced ultrasound to evaluate the anti-angiogenic effects of bevacizumab.
Zhang HP; Shi QS; Li F; Liu L; Bai M; Gu JY; Wu Y; Du LF
Mol Med Rep; 2013 Jul; 8(1):154-60. PubMed ID: 23722237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
